What do Definium Therapeutics’ Panorama results mean for DT120 FDA approval?
Definium’s DT120 delivers another positive Phase 3 anxiety result, putting the FDA filing and commercialization strategy firmly in focus.
Pharma & Biotech
Pharma & Biotech
Can Definium turn a 50% stock surge into an FDA path for single-dose depression therapy?
DT120 produced a striking Phase 3 antidepressant effect after one supervised dose, but confirmation, functional unblinding, controlled-substance rules and treatment-site economics remain decisive.